CFO stock award at Alto Ingredients (ALTO) adds 35,730 shares

Rhea-AI Filing Summary

Olander Robert R. reported acquisition or exercise transactions in this Form 4 filing.

Alto Ingredients, Inc. reported that Chief Financial Officer Robert R. Olander received a grant of 35,730 shares of Common Stock on 2026-03-17. The award was recorded at a price of $0.0000 per share, indicating a compensation-related stock grant rather than a market purchase. Following this grant, Olander directly holds 294,158 shares of Alto Ingredients common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Olander Robert R.

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	35,730	$0.00	--

Holdings After Transaction: Common Stock — 294,158 shares (Direct)

Footnotes (1)

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Olander Robert R.

(Last) (First) (Middle)

1300 SOUTH SECOND STREET

(Street)

PEKIN ILLINOIS 61554

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Alto Ingredients, Inc. [ ALTO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/17/2026		A		35,730	A	$0.00	294,158	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Robert R. Olander	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Alto Ingredients (ALTO) report for its CFO?

Alto Ingredients reported that CFO Robert R. Olander received a grant of 35,730 shares of Common Stock. The shares were awarded at a recorded price of $0.0000 per share as a compensation-related grant, not an open-market purchase or sale.

How many Alto Ingredients (ALTO) shares does the CFO hold after this Form 4?

After the reported stock grant, CFO Robert R. Olander directly holds 294,158 shares of Alto Ingredients Common Stock. This total reflects his position following the 35,730-share compensation award disclosed in the Form 4 insider filing.

Was the Alto Ingredients (ALTO) CFO transaction a stock purchase or sale?

The transaction was classified as an acquisition by grant or award, not a market purchase or sale. The Form 4 uses transaction code “A” and describes it as a grant, with a per-share price of $0.0000, indicating a compensation-related issuance.

What does transaction code “A” mean in the Alto Ingredients (ALTO) Form 4?

Transaction code “A” in this Form 4 represents a grant, award, or other acquisition of shares. For Alto Ingredients, it shows the CFO received 35,730 Common Stock shares as a stock award rather than buying them on the open market.

Does the Alto Ingredients (ALTO) CFO grant involve derivative securities or options?

The reported transaction involves non-derivative Common Stock only, with 35,730 shares granted directly. The derivativeSummary section is empty in this filing, indicating no related option or other derivative exercises were reported alongside this stock award.